Plus, rheumatology drug news, safety updates
EULAR 2014: Collaboration Among Rheumatology Groups Expected to Build
ACR, European League Against Rheumatism, other groups, to work together creating disease criteria and response sets, patient management guidelines
Vaccinations for Immunocompromised Patients Are Shared Responsibility of Specialists, Primary Care Physicians
Infectious Diseases Society of America recommends both physician groups educate patients, household members on importance of vaccines
Metabolic Syndrome Linked to Higher Risk for Immunological Disorders
Research suggests patients with metabolic disorders, such as diabetes, might benefit from antiinflammatory drugs used to treat immunlogical disorders
Kidney Problems More Prevalent in Patients with Rheumatoid Arthritis
Rheumatologists urged to monitor signs of kidney dysfunction in patients with RA as higher incidence of reduced kidney function found in these patients
Coding Corner Answer: September
Coding for first infliximab infusion in patient with rheumatoid arthritis
Coding Corner Question: September
Coding for first infliximab infusion in patient with rheumatoid arthritis
Update on Legislation, Advocacy Efforts to Advance Rheumatology
Status of progess to fix sustainable growth rate physician formula, other rheumatology-related issues facing Congress
Drugs Studied for Use in Rheumatoid Arthritis, Weight Loss
Plus, rheumatology drug news from EULAR 2014
EULAR 2014: Non-Tumor Necrosis Factor Biologics Update
Clinical trials on rheumatology drugs, including sarilumab, show promise for patients with rheumatoid arthritis also taking methotrexate
- « Previous Page
- 1
- …
- 110
- 111
- 112
- 113
- 114
- …
- 125
- Next Page »